Institutional investors hold a majority ownership of MYGN through the 134.72% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2015, these large investors purchased a net $1.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 878.9 Thousand shares of Myriad Genetics Inc
FRONTIER CAPITAL MANAGEMENT CO. ... Bought 494.3 Thousand shares of Myriad Genetics Inc
D. E. SHAW & CO. LP Bought 486.3 Thousand shares of Myriad Genetics Inc